Natalie E. Dakers

LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada.

BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada.

FortisBC Energy, Inc. engages in the distribution of natural gas. It provides transmission and distribution services to its customers, as well as obtains natural gas supplies on behalf of residential, commercial, and industrial customers. The company was founded in 2003 and is headquartered in Vancouver, Canada.

Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada.

Bruce Power LP operates nuclear power generating facilities. The firm is involved in the electricity wholesale market in Ontario and also sells electricity at the retail level in Ontario. The company was founded in 2001 and is headquartered in Tiverton, Canada.

Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada.

FortisBC, Inc. engages in the provision of natural gas, electricity, alternative energy and related services. The firm owns and operates a network of generation, transmission and distribution assets. The company was founded on May 8, 1897, and is headquartered in Kelowna, Canada.

Northwestel, Inc. provides telecommunication solutions for residents. The firm's services include local telephone service, long distance communications by microwave radio, fiber optic cable, satellite and advanced data communications. The company was founded in January, 1979 and is located in Whitehorse, Canada

The Bell Telephone Company of Canada engages in the provision of communications services. It includes residential, business, and wholesale customers with a range of solutions to all their communications needs, such as wireless, television, internet, home phone, and small business and enterprise communications services. The company was founded in 1880 and is headquartered in Verdun, Canada.

OMERS Infrastructure Management Inc (Omers Infrastructure) is a private equity subsidiary OMERS Administration Corp of founded in 1998 by Douglas Clive Betts. The firm is headquartered in Toronto, Canada.

British Columbia Ferry Services, Inc. engages in the provision of coastal ferry services. It connects coastal communities and facilitates the movement of people, goods, and services. The firm focuses on Skeena Queen mid-life upgrade, pacific buffet - beer and wine pilot, ferries for the next generation, BC Ferries' island class, smoke-free environment, horseshoe bay terminal engagement, and lower closed vehicle deck access onboard projects. The company was founded in 1960 and is headquartered in Victoria, Canada.

Triphase Accelerator Corp. develops oncology drug therapeutics. It engages in accelerating oncology products from pre-investigational new drug (pre-IND) to Phase I/Phase II POC. The firm?s product includes Marizomib which is used in cancer treatment. The company is headquartered in Toronto, Canada.

Clinical Trials Ontario operates as a research and development company for various diseases. The company was founded in 2012 and is headquartered in Toronto, Canada.

Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel.

Bedside Clinical Systems, Inc. develops Responses to Illness Severity Quantification (RISQ) framework severity of illness clinical decision support for frontline healthcare professionals, hospital administrators and quality managers. It provides BedsidePEWS, that uses the RISQ framework to empower frontline clinicians who care for hospitalized children. The company was founded by Christopher Parshuram in March 2011 and is headquartered in Toronto, Canada.

Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada.

QD Solar, Inc. develops photovoltaic cells using colloidal quantum dot technology in Canada. Its quantum dot technology combines silicon solar cells with infrared solar cells in a hybrid architecture to harvest more of the solar spectrum than silicon alone. The company was founded by Sjoerd Hoogland and Edward Hartley Sargent in 2014 and is headquartered in Toronto, Canada.

Encycle Therapeutics, Inc. provides biotechnology services. It offers rapid synthesis of drug-like macrocycles or membrane-permeable nacellins which have enormous potential to target intracellular protein-protein interactions. The company was founded by Andrei Yudin is headquartered in Toronto, Canada.

Bio-MarCare Technologies Ltd. develops diagnostic kits based on novel biomarkers for early cancer identification, monitoring and assistance. Its product mCRC-Strat is a personalized medicine assay predicting responsiveness to anti EGFR therapy and Colon-MarCarePlex is a molecular assay (qRT-PCR) comprising a panel of RNA markers that can detect the advanced adenoma polyps as well as early stage colorectal cancer. The company was founded by Beatrice Uziely and Rachel Bar-Shavit in 2002 and is headquartered in Jerusalem, Israel.

Killam Trusts operates as philanthropic trusts for higher education in Canada. It engages in funding scholarships for graduate students, postdoctoral fellows and faculty. The company was founded in 1965 and is headquartered in Halifax, Canada.

Westland Insurance Group Ltd. engages in the provision of insurance services. It offers insurance for automobile, home, tenant, business, commercial, and liability. The company was founded in 1980 and is headquartered in Surrey, Canada.

British Columbia Hydro & Power Authority is engaged in generation and distribution of electricity. The company's primary business activities are generation, distribution and transmission of electricity. It provides engineering, extension and connection, emergency response and restoration, vehicle fleet and material supply chain services. The company was founded in 1961 and is headquartered in Vancouver, Canada

Forticell Bioscience, Inc. focuses on advanced regenerative medicine and stem cell therapy. The company was founded in 1991 and is headquartered in Englewood Cliffs, NJ.

Hadasit Medical Research Services & Development Ltd. operates as technology transfer company of Hadassah Medical Center in Jerusalem. It identifies, protects, nurtures and commercializes the discoveries made at Hadassah Medical Center. The company's product include Doxil, Periochip, Travelan, Granagard, and Insupad. The company was founded on December 7, 1986 and is headquartered in Jerusalem, Israel.

Hadasit Bio-Holdings Ltd. /Private Equity/ (Hadasit Bio-Holdings /Private Equity/) is a private equity division of Hadasit Bio-Holdings Ltd. founded in 2005. The firm is headquartered in Jerusalem, Israel.

LifeBond Ltd. engages in the development of medical devices designed to restore and repair tissues to reduce post-operative complications. The company was founded by Nir Mashkif, Orahn Preiss-Bloom and Ishay Attar in 2007 and is headquartered in Caesarea, Israel.

KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel.

Toronto Innovation operates as a commercialization agent. Its technologies disclosed span therapeutics, medical devices and diagnostic imaging, information and communications technologies, and advanced manufacturing and clean technologies. The company was founded by Raphael Hofstein in June 2009 and is headquartered in Toronto, Canada.